BLOG | From the Desk of Dr. Karl R.O.S. Johnson, DC | Shelby Township

gammaCore Sapphire for Migraine: Relief Beyond the Pill

Written by Dr. Karl R.O.S. Johnson, DC | Tue, Nov 10, 2026

If you have ever had to cancel plans, leave work early, or retreat to a dark room because of a migraine, you already know that this condition controls more than just your head. It affects your entire life. You may have tried multiple conventional options and still find yourself searching for something that works differently.

At Johnson Chiropractic Neurology & Nutrition, my approach considers the whole person, including factors that may contribute to repeated attacks.

In this article, I want to explain how a device called gammaCore Sapphire uses non-invasive vagus nerve stimulation to help treat and prevent migraines, what clinical research shows, including its limits, and how it may fit into an individualized care plan alongside functional medicine, functional neurology, and appropriate chiropractic care.

AI-generated illustration based on Dr. Johnson’s headshot; not an actual patient encounter.

Key Takeaways: gammaCore Sapphire for Migraine

  • gammaCore Sapphire is an FDA-cleared, prescription-only device that delivers non-invasive vagus nerve stimulation through the neck to treat and help prevent migraine.
  • Clinical research suggests nVNS may provide pain relief starting as early as 30 minutes, though primary endpoints in key trials require careful interpretation.
  • Johnson Chiropractic Neurology & Nutrition offers gammaCore Sapphire as one component within personalized, multimodal migraine care plans.
  • Vagus nerve stimulation targets neurological pain signaling pathways rather than introducing chemicals into the body and may be used alongside prescribed care.
  • A clinical screening and prescription are required before using gammaCore Sapphire, with specific safety considerations your provider should review with you.

How Does gammaCore Sapphire Work?

gammaCore Sapphire is a handheld, rechargeable medical device made by electroCore. It delivers gentle electrical stimulation to the vagus nerve through the skin on the side of your neck. This approach is called non-invasive vagus nerve stimulation, or nVNS.

The vagus nerve is one of the longest nerves in your body. Think of it as a major communication highway connecting your brain to your heart, lungs, digestive system, and many other organs. It plays a central role in regulating inflammation, pain perception, and the balance between your body’s alert and recovery responses.

Research supports the idea that stimulating this nerve at the neck activates specific brain regions involved in pain processing. A 2017 fMRI study by Frangos and Komisaruk confirmed that cervical vagus nerve stimulation through the skin activates brainstem nuclei, including areas that help process incoming nerve signals [3]. Separately, Nonis et al. (2017) demonstrated through electrophysiology that nVNS at the neck activates nerve pathways carrying signals toward the brain in healthy volunteers [2].

As described in the manufacturer’s device overview, gammaCore is portable and adjustable. Each stimulation takes two minutes; a prescribed treatment may include more than one stimulation. Your prescribing clinician determines how many stimulations per day are appropriate for your situation, up to a maximum of 24 stimulations as specified in the device labeling.

What Does Research Show About gammaCore for Acute Migraine Relief?

electroCore’s clinical efficacy page highlights the PRESTO study (Tassorelli et al., 2018), a study that compared active stimulation with a sham device in 243 adults with episodic migraine [1].

I want to be transparent about what this study found, because the details matter.

Early Relief and the Study’s Main Goal

The study’s main goal was complete freedom from pain at two hours. Before looking at the results, it helps to understand the small numbers labeled “p” below.

What Does a P-Value Mean?

A p-value helps researchers ask: If the treatment and comparison really worked equally well, how surprising would results like these be? A smaller p-value means the results would be less expected under that assumption and the statistical model used.

For example, p = 0.012 means that, assuming there is no real difference and the study’s statistical assumptions hold, results this extreme or more extreme would occur about 1.2% of the time. It does not mean there is a 98.8% chance the treatment works.

Researchers often use p < 0.05 as the cutoff for “statistically significant.” A result above that cutoff, such as p = 0.067, does not prove a treatment has no benefit. It means that result did not meet the chosen cutoff.

A p-value also does not tell you how much relief you might feel or whether a treatment is right for you. I consider the size of the benefit, study quality, safety, and your health history alongside these numbers [8]. 

How to Read the PRESTO Results

  • The primary endpoint was pain freedom at 120 minutes after treating the first migraine attack.
  • On this primary measure, gammaCore did not reach statistical significance compared to sham (30.4% versus 19.7%, p = 0.067).
  • Pain freedom at 30 minutes was statistically significant: 12.7% for nVNS versus 4.2% for sham (p = 0.012).
  • Pain freedom at 60 minutes was also significant: 21.0% versus 10.0% (p = 0.023).
  • An extra analysis performed after the original study plan also found benefit. Such findings are useful, but less conclusive than meeting the study’s main goal.

"Pain relief" (a drop from moderate or severe pain to mild or no pain) and "pain freedom" (complete elimination of pain) are different measures. The PRESTO data showed meaningful pain relief at 120 minutes even when complete pain freedom did not reach statistical significance.

Consistency Across Multiple Attacks

According to electroCore’s efficacy summary [6], when researchers evaluated all treated migraine attacks rather than only the first, nearly half of the patients using gammaCore reported mild or no pain at 120 minutes for more than 50% of their treated attacks. gammaCore also reduced the need for rescue interventions during the study period.

Can gammaCore Sapphire Help Prevent Migraines?

The PREMIUM trial (Diener et al., 2019) was a study of migraine prevention in 332 participants in its main analysis [4]. Active stimulation was compared with a sham device.

What the PREMIUM Trial Found

  • The main analysis did not establish a significant advantage over sham: nVNS reduced migraine days by 2.26 versus 1.80 for sham (p = 0.15).
  • An additional analysis of 278 people who followed at least 67% of the monthly treatment schedule showed a statistically significant difference: 2.27 versus 1.53 fewer migraine days (p = 0.043).
  • In this group, people with aura appeared to benefit more. Aura can include temporary visual changes or other sensory symptoms.

Because the positive findings came from an extra analysis rather than the study’s main planned test, they suggest possible benefit rather than prove it for everyone. The trial does suggest that consistent daily use may matter for preventive benefit.

gammaCore also has FDA clearance for cluster headache, but cluster headache and migraine are distinct conditions with different underlying mechanisms. The cluster headache evidence (PREVA, ACT1, ACT2 trials) does not directly apply to migraine and should not be confused with the migraine-specific results above.

How nVNS Compares to Conventional Migraine Approaches

Conventional migraine approaches generally work by altering brain chemistry or blocking specific receptors. nVNS works through a fundamentally different pathway: it modulates neurological pain signaling by stimulating the vagus nerve rather than delivering a drug [7]. These studies do not establish that gammaCore works better than a specific prescription treatment.

This does not mean nVNS is a replacement for your current prescribed care. You should always continue any treatment your prescriber has recommended unless they advise otherwise. nVNS may serve as an adjunct option, used alongside other approaches under clinical guidance.

Some practical considerations that distinguish nVNS from conventional approaches:

  • nVNS offers a non-drug option without the medication-overuse headache concern associated with some acute medicines. It still has use limits and safety precautions.
  • The side-effect profile is generally mild, with the most common reports being temporary skin irritation or discomfort at the stimulation site.
  • It is portable for use in a safe setting, and each individual stimulation lasts two minutes.
AI-generated illustration of a consultation. It does not depict an actual patient or Dr. Johnson

How gammaCore Fits into My Multimodal Migraine Approach

My multimodal approach combines several forms of care based on your history and findings. Migraine is a neurological condition, and no single tool works for everyone. My care options support an individualized plan rather than a fixed package.

At Johnson Chiropractic Neurology & Nutrition, I combine functional neurology, functional medicine, integrative care, and appropriate chiropractic adjustments to explore factors that may contribute to your symptoms. gammaCore Sapphire may be one component of that plan. The gammaCore studies did not test my complete multimodal approach, so their results should not be presented as proof of the combined program.

  • Functional neurology considers nervous system function as part of an individualized assessment. Findings help guide care; they do not identify one universal cause of migraine.
  • Nutritional evaluation may reveal inflammatory triggers, nutrient deficiencies, or metabolic imbalances that lower your migraine threshold.
  • Chiropractic care may address coexisting neck pain or movement limitations when appropriate. This does not mean every migraine comes from a spinal problem.
  • gammaCore Sapphire may serve as an additional tool for acute relief during attacks and as a preventive measure between visits, when clinically appropriate.
Explore possible contributing factors with Dr. Karl R.O.S. Johnson, DC

Take the Next Step Toward Personalized Migraine Care

Make room for more of the life you enjoy. Call 586-731-8840 to request a migraine case review. Let’s explore your history, your goals, and which care options may fit your needs.

Call to Request a Migraine Case Review

If you are dealing with disruptive migraines and want to explore a natural, whole-person approach, here are the steps to get started:

  1. Call 586-731-8840 to schedule a case review at Johnson Chiropractic Neurology & Nutrition in Shelby Township, Michigan.
  2. Complete a thorough health history review so I can understand your migraine patterns, prior interventions, and contributing factors.
  3. Receive a personalized care plan that may include functional neurology assessments, nutritional evaluation, appropriate chiropractic care, and technologies like gammaCore Sapphire where clinically indicated.

Ask About Renting gammaCore Sapphire from My Office

Could at-home vagus nerve stimulation fit your care? Call 586-731-8840 and ask about renting gammaCore Sapphire from my office. We can discuss clinical suitability, rental terms, and proper training before you decide.

Call to Ask About gammaCore Rental

gammaCore Sapphire is a prescription device that requires a clinical evaluation before use. If you are interested in exploring whether it may be appropriate for your migraine care, call 586-731-8840 to inquire about:

  • Availability and eligibility requirements
  • Rental terms and how the process works
  • Hands-on training so you learn to use the device properly
  • Ongoing clinical oversight as part of your individualized care plan

Who Should Review gammaCore Safety Before Use?

gammaCore Sapphire is FDA-cleared for the preventive and acute treatment of migraine in patients aged 12 and older. It is prescription-only and requires evaluation by a licensed healthcare provider.

Review the manufacturer’s important safety information with your clinician. Do not use the device while driving or share it with another person.

The clinical safety profile across multiple randomized trials has been favorable, with most device-related adverse events being mild and transient (primarily application-site discomfort). However, several important safety considerations apply:

  • Active implantable devices: gammaCore should not be used by individuals with an active implantable medical device such as a pacemaker, hearing aid implant, or implanted electronic device.
  • Metallic implants: Safety and effectiveness have not been evaluated in people with metallic implants at or near the neck. This differs from the contraindication for active implanted electronics.
  • Pregnancy and cardiovascular conditions: Safety and effectiveness have not been evaluated during pregnancy or in several cardiovascular conditions. Review the full labeling with your clinician before considering use.
  • Not risk-free: While generally well tolerated, no medical device carries zero risk. Screening helps assess suitability but cannot guarantee safety or benefit.

Seek urgent medical attention for a sudden, extremely severe headache, new weakness, trouble speaking, or a headache with fever and a stiff neck. Do not assume an unusual headache is your usual migraine.

Frequently Asked Questions About gammaCore Sapphire for Migraine

What is gammaCore Sapphire used for?

gammaCore Sapphire is an FDA-cleared, handheld device for the acute treatment and prevention of migraine in patients aged 12 and older. It delivers non-invasive vagus nerve stimulation through the skin on the side of the neck. Johnson Chiropractic Neurology & Nutrition includes gammaCore Sapphire as one element within broader, individualized migraine care.

How quickly does gammaCore provide migraine relief?

In the PRESTO clinical trial, statistically significant pain freedom occurred as early as 30 minutes after treatment (Tassorelli et al., 2018). Results varied between individuals, and the primary 120-minute pain freedom endpoint did not reach statistical significance. Pain relief, which measures improvement rather than complete elimination, showed additional benefit at two hours.

Does gammaCore Sapphire prevent migraines?

The PREMIUM trial did not reach significance for migraine prevention in the full main-analysis group (Diener et al., 2019). An additional analysis of people who followed at least 67% of the treatment schedule showed a statistically significant reduction in migraine days. At Johnson Chiropractic Neurology & Nutrition, we consider gammaCore alongside a review of factors that may contribute to repeated attacks.

Is gammaCore safe to use?

gammaCore has demonstrated a generally favorable safety profile in clinical trials. The most common device-related effects are mild, temporary skin irritation and application-site discomfort. Specific contraindications include active implanted electronic devices, and pregnancy and cardiovascular conditions require clinical review. No device is risk-free, so a thorough screening with your provider is an important first step.

Can I use gammaCore alongside my current prescribed care?

Yes. gammaCore is designed to be used as an adjunct to other care approaches, not as a replacement. Continue any prescribed care unless your prescriber advises otherwise. Your provider should coordinate how gammaCore fits into your overall plan.

Do I need a prescription for gammaCore Sapphire?

Yes. gammaCore Sapphire is prescription-only. A licensed healthcare provider must evaluate your health history and determine that vagus nerve stimulation is appropriate for you. To start the process at our Shelby Township office, call 586-731-8840.

Explore a More Complete Plan for Your Migraines

If you or someone you care about is struggling with migraines that have not responded to conventional care, consider whether a deeper investigation into the possible contributing factors might be worth pursuing.

Please use the social sharing icons at the top of this post to share this article with them. It may help them ask new questions and explore additional care options. Thank you for helping me reach others who are searching for answers and a fuller life.

Could there be another piece of the puzzle to explore in your migraine care?

If you’d like to understand more about the natural, whole-person approach that guides my work, I invite you to explore what makes my philosophy of care unique.

Always remember one of my guiding principles: the more you understand how your body works, the better you can care for yourself and support your long-term health.

For a deeper look at the natural, whole-person approach I use with my patients, you may enjoy my book, Reclaim Your Life: Your Guide To Revealing Your Body’s Life-Changing Secrets For Renewed Health. It is available in my office, on Amazon, and through many other booksellers.

ALL THE BEST – DR. KARL R.O.S. JOHNSON, DC – DIGGING DEEPER TO FIND SOLUTIONS 

References:

  1. Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364-e373. PubMed.
  2. Nonis R, D'Ostilio K, Schoenen J, Magis D. Evidence of activation of vagal afferents by non-invasive vagus nerve stimulation: an electrophysiological study in healthy volunteers. Cephalalgia. 2017;37(13):1285-1293. doi:10.1177/0333102417717470
  3. Frangos E, Komisaruk BR. Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans. Brain Stimulation. 2017;10(1):19-27. doi:10.1016/j.brs.2016.10.008
  4. Diener HC, Goadsby PJ, Ashina M, et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia. 2019;39(12):1475-1487. PubMed.
  5. gammaCore. About gammaCore. Device overview.
  6. gammaCore Sapphire Clinical Efficacy. electroCore, Inc. gammacore.com/prescribing-gammacore/clinical-efficacy. Accessed 2026.
  7. nVNS vs. Prescription Drugs: Benefits, Drawbacks, and Effectiveness. electroCore, Inc. gammacore.com. Published May 2026.
  8. American Statistical Association. Statement on Statistical Significance and P-Values. 2016. Principles for interpreting p-values.